Sign up to save your podcasts
Or
Share H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022.
Read the Study
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022.
Read the Study
More shows like Neuro-Oncology: The Podcast
View all
Wait Wait... Don't Tell Me!
38,713 Listeners
This American Life
90,949 Listeners
Neurology® Podcast
293 Listeners
Science Vs
12,103 Listeners
Radio Atlantic
2,327 Listeners
Armchair Expert with Dax Shepard
69,085 Listeners
Call Her Daddy
165,736 Listeners
Conan O’Brien Needs A Friend
59,371 Listeners
The Cribsiders
317 Listeners
IMO with Michelle Obama and Craig Robinson
12,540 Listeners
Huberman Lab
28,507 Listeners
The Ezra Klein Show
15,335 Listeners
If Books Could Kill
8,874 Listeners
Not Gonna Lie with Kylie Kelce
9,964 Listeners
Good Hang with Amy Poehler
7,654 Listeners